142 related articles for article (PubMed ID: 8648774)
1. Survival in blacks and whites after treatment for localized prostate cancer.
Fowler JE; Terrell F
J Urol; 1996 Jul; 156(1):133-6. PubMed ID: 8648774
[TBL] [Abstract][Full Text] [Related]
2. Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment.
Fowler JE; Bigler SA; Bowman G; Kilambi NK
J Urol; 2000 Jan; 163(1):137-42. PubMed ID: 10604331
[TBL] [Abstract][Full Text] [Related]
3. Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy.
Fowler JE; Terrell FL; Renfroe DL
J Urol; 1996 Nov; 156(5):1714-8. PubMed ID: 8863577
[TBL] [Abstract][Full Text] [Related]
4. Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: radiation oncology report of the Department of Defense Center for Prostate Disease Research.
Johnstone PA; Kane CJ; Sun L; Wu H; Moul JW; McLeod DG; Martin DD; Kusuda L; Lance R; Douglas R; Donahue T; Beat MG; Foley J; Baldwin D; Soderdahl D; Do J; Amling CL
Radiology; 2002 Nov; 225(2):420-6. PubMed ID: 12409575
[TBL] [Abstract][Full Text] [Related]
5. Experience with radical prostatectomy and radiation therapy for localized prostate cancer at a Veterans Affairs Medical Center.
Fowler JE; Braswell NT; Pandey P; Seaver L
J Urol; 1995 Mar; 153(3 Pt 2):1026-31. PubMed ID: 7853550
[TBL] [Abstract][Full Text] [Related]
6. Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration.
Wood HM; Reuther AM; Gilligan TD; Kupelian PA; Modlin CS; Klein EA
J Urol; 2007 Oct; 178(4 Pt 1):1271-6. PubMed ID: 17698101
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.
Bianco FJ; Wood DP; Grignon DJ; Sakr WA; Pontes JE; Powell IJ
J Urol; 2002 Aug; 168(2):479-82. PubMed ID: 12131292
[TBL] [Abstract][Full Text] [Related]
8. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
[TBL] [Abstract][Full Text] [Related]
10. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system.
Optenberg SA; Thompson IM; Friedrichs P; Wojcik B; Stein CR; Kramer B
JAMA; 1995 Nov 22-29; 274(20):1599-605. PubMed ID: 7474244
[TBL] [Abstract][Full Text] [Related]
11. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer.
Eastham JA; Kattan MW
J Urol; 2000 Jan; 163(1):143-5. PubMed ID: 10604332
[TBL] [Abstract][Full Text] [Related]
12. The influence of race on the efficacy of curative radiation therapy for carcinoma of the prostate.
Hart KB; Porter AT; Shamsa F; Chuba PJ; Pontes JE; Forman JD
Semin Urol Oncol; 1998 Nov; 16(4):227-31. PubMed ID: 9858330
[TBL] [Abstract][Full Text] [Related]
13. Race, prostate cancer survival, and membership in a large health maintenance organization.
Robbins AS; Whittemore AS; Van Den Eeden SK
J Natl Cancer Inst; 1998 Jul; 90(13):986-90. PubMed ID: 9665146
[TBL] [Abstract][Full Text] [Related]
14. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system.
Powell IJ; Schwartz K; Hussain M
Urology; 1995 Dec; 46(6):825-30. PubMed ID: 7502424
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer.
Godley PA; Schenck AP; Amamoo MA; Schoenbach VJ; Peacock S; Manning M; Symons M; Talcott JA
J Natl Cancer Inst; 2003 Nov; 95(22):1702-10. PubMed ID: 14625261
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma.
Fowler JE; Bigler SA
Cancer; 1999 Sep; 86(5):836-41. PubMed ID: 10463983
[TBL] [Abstract][Full Text] [Related]
17. Percent free prostate specific antigen and cancer detection in black and white men with total prostate specific antigen 2.5 to 9.9 ng./ml.
Fowler JE; Sanders J; Bigler SA; Rigdon J; Kilambi NK; Land SA
J Urol; 2000 May; 163(5):1467-70. PubMed ID: 10751859
[TBL] [Abstract][Full Text] [Related]
18. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut.
Polednak AP; Flannery JT
Cancer; 1992 Oct; 70(8):2152-8. PubMed ID: 1394045
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer incidence and mortality rates among white and black men.
Merrill RM; Brawley OW
Epidemiology; 1997 Mar; 8(2):126-31. PubMed ID: 9229202
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics in black and white men with prostate cancer in an equal access medical center.
Freedland SJ; Sutter ME; Naitoh J; Dorey F; Csathy GS; Aronson WJ
Urology; 2000 Mar; 55(3):387-90. PubMed ID: 10699616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]